United States Patent Application: 0050162539

نویسندگان

  • Michael R. Feldman
  • David Taylor
چکیده

An imaging system includes an array of lenses, a plurality of sensor pixels for each lens, the sensor pixels being on an image plane of the imaging system, and a corresponding plurality of focal plane coding elements. A focal plane coding element for each sensor pixel has multiple sub-pixel resolution elements. The focal plane coding element being between the lens and each sensor pixel, wherein sub-pixel resolution elements over the plurality of focal plane coding elements represent a selected transform matrix having a non-zero determinant. The output of the plurality of sensor pixels being an image multiplied by this matrix

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Heart Carcinoid Disease with Patent Foramen Ovale Treated by Mini Sternotomy

This case report was an attempt to present the importance of diagnostic echocardiography and closure of a patent foramen ovale in carcinoid heart disease. Herein, we present a case of a 48-year-old woman with a carcinoid metastasis presenting with tricuspid regurgitation, pulmonic stenosis, patent foramen ovale, and borderline left ventricular ejection fraction on an echocardiogram. Surgical in...

متن کامل

In the United States Patent and Trademark Office

IN THE UNITED STATES PATENT AND TRADEMARK OFFICE In re Application of: RICHARD H. STERN APPLICATION MADE SPECIAL Serial No.: 11/166,991 Examiner: HARRIS, CHANDA L. Filed: 27 June 2005 Art Unit: 3715 For: MENTAL THERAPY METHOD FOR CATHARSIS OF NEGATIVE FEELINGS AMENDMENT Paper No. 6 Commissioner for Patents P.O. Box 1450 Alexandria, VA 22313-1450 Sir: In response to the first Office action maile...

متن کامل

Determination of regulatory review period for purposes of patent extension; Therma Choice Uterine Ballon Therapy System. Food and Drug Administration, HHS. Notice.

The Food and Drug Administration (FDA) has determined the regulatory review period for Therma Choice5 Uterine Ballon Therapy System and is publishing this notice of that determination as required by law. FDA has made the determination because of the submission of an application to the Commissioner of Patents and Trademarks, Department of Commerce, for the extension of a patent which claims tha...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2006